HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
0 Visningar
• 07/03/23
0
0
Bädda in
administrator
Prenumeranter
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna